Prognostic significance of alterations of pathways regulating autophagy in acute myeloid leukemia.
Giovanni Marconi(University of Bologna), Giovanni Martinelli(University of Bologna), Andrea Ghelli Luserna di Rorà(Fondazione Pisa), Chiara Sartor(University of Bologna), Maria Chiara Fontana(Istituto Oncologico Romagnolo), Maria Chiara Abbenante(University of Bologna), Emanuela Ottaviani(University of Bologna), Silvia Lo Monaco(University of Bologna), Jacopo Nanni(Istituto di Ematologia di Bologna), Cristina Papayannidis(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Giorgia Simonetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Nicoletta Testoni(Thrombolysis in Myocardial Infarction Study Group), Elena Tenti(University of Bologna), Antonella Padella(University of Bologna), Carmen Baldazzi(University of Bologna), Eugenio Fonzi(University of Bologna), Luca Bertamini(University of Verona), Valentina Robustelli(University of Bologna)
Cited by 2
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644